Project Dulce for Filipino-Americans With Type 2 Diabetes
2 other identifiers
interventional
29
1 country
2
Brief Summary
This study aims to culturally adapt an existing American Diabetes Association (ADA)-recognized diabetes self-management and support or DSMES (Diabetes Self Management Education Support) program (Project Dulce) and integrate an evidence-based text messaging program (Dulce Digital) for implementation in Filipino Americans (FAs) with type 2 diabetes mellitus (T2DM). Cultural adaptations aims to facilitate and enhance patient centered approaches and increase participant engagement by addressing barriers to DSMES unique to FAs, such as linguistic challenges, health literacy and numeracy, cultural beliefs and values, and technology access and use. In addition, this study aims to examine the effectiveness of the culturally and digitally adapted Project Dulce + Dulce Digital in improving diabetes knowledge, belief, attitudes, hemoglobin A1C (glycosylated hemoglobin), and self-management behaviors at baseline to 3 months and 6 months. The unprecedented increase of T2DM prevalence among racial and ethnic minority populations including FAs in recent decades demands for effective strategies to meet the needs in DSMES in this population. The outcomes of the current study will demonstrate that the culturally adapted Project Dulce and integration of Dulce Digital is effective in addressing the needs FAs, an underserved racial and ethnic minority group in high need of culturally appropriate DSMES.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2022
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 10, 2022
CompletedFirst Posted
Study publicly available on registry
May 18, 2022
CompletedStudy Start
First participant enrolled
October 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 12, 2025
CompletedMarch 4, 2026
March 1, 2026
3.2 years
May 10, 2022
March 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change from Baseline Diabetes Knowledge at 3 months
Diabetes Knowledge Test (Fitzgerald, Funnell, Anderson, et al., 2016) is a 23-item measure of diabetes knowledge, with general questions related to symptoms, self-management (e.g., diet, exercise, foot care, blood glucose monitoring, insulin) , and complications (e.g., low and high blood sugar). Greater scores indicate greater diabetes knowledge.
3 months
Change from Baseline Diabetes Knowledge at 6 months
Diabetes Knowledge Test (Fitzgerald, Funnell, Anderson, et al., 2016) is a 23-item measure of diabetes knowledge, with general questions related to symptoms, self-management (e.g., diet, exercise, foot care, blood glucose monitoring, insulin) , and complications (e.g., low and high blood sugar). Greater scores indicate greater diabetes knowledge.
6 months
Change in Baseline Self-Efficacy for Diabetes Scale at 3 months
Stanford Self-Efficacy for Diabetes Scale (Lorig, Stewart, Ritter, et al., 1996) is comprised of 8 items that measure the confidence of a participant in performing self-care activities such as eating meals every 4 to 5 hours, following a healthful diet, exercising, and blood glucose monitoring. Response options range from 1=not at all confident to 10=totally confident, with higher scores indicating greater self-efficacy.
3 months
Change in Baseline Self-Efficacy for Diabetes Scale at 6 months
Stanford Self-Efficacy for Diabetes Scale (Lorig, Stewart, Ritter, et al., 1996) is comprised of 8 items that measure the confidence of a participant in performing self-care activities such as eating meals every 4 to 5 hours, following a healthful diet, exercising, and blood glucose monitoring. Response options range from 1=not at all confident to 10=totally confident, with higher scores indicating greater self-efficacy.
6 months
Secondary Outcomes (8)
Change in Baseline Summary of Diabetes Self-Care Activities at 3 months
3 months
Change in Baseline Summary of Diabetes Self-Care Activities at 6 months
6 months
Change in Baseline Block Food Frequency Questionnaire at 3 months
3 months
Change in Baseline Block Food Frequency Questionnaire at 6 months
6 months
Change in Baseline International Physical Activity Questionnaire-Short Form at 3 months
3 months
- +3 more secondary outcomes
Other Outcomes (2)
Recruitment and Retention
6 months
Participant Satisfaction
6 months
Study Arms (1)
Project Dulce + Dulce Digital
OTHERPatients will participate in a peer-led group diabetes self-management education and support program and receive ongoing support via text messages designed to improve knowledge, health beliefs, self-management behaviors and clinical outcomes.
Interventions
Project Dulce will consist of a group diabetes self-management program consisting of a 5-week curriculum delivered by a peer educator in Tagalog. The curriculum provides new knowledge as well as skills and tools needed to adapt to a life with diabetes and change behaviors. The curriculum covers diabetes and its complication, the role of diet, exercise, and medication, and the importance of self-monitoring. It is presented over 5 weeks where participants will learn and practice self-management skills, and help one another address family, cultural, or health system barriers to managing your diabetes. Following the 5-week curriculum, participants will be enrolled in the digital texting platform, Dulce Digital, in which they will receive on-going support via text messages derived from the curriculum, medication reminders, and blood glucose monitoring prompts in Tagalog.
Eligibility Criteria
You may qualify if:
- Self-identified Filipino
- Diagnosed with T2DM
- Registered at Scripps Health or San Ysidro Health (or willing to register)
- HbA1c ≥7.5% and/or systolic blood pressure ≥ 140, and/or LDL-C ≥ 100 mg/dL within 90 days
- Able to speak, read, write, and comprehend in English and Tagalog
- Have access to a cell phone that can receive/send text messages throughout the study
You may not qualify if:
- Severe illness precluding frequent visits to clinic
- Liver function tests (ALT and AST) \> 3 times the upper limit of normal
- Body mass index ≤ 23 kg/cm
- History of malignancy, except subjects who have been disease-free for \>years, or whose only malignancy has been basal or squamous cell skin carcinoma
- Creatinine \>3.5
- History of drug or alcohol abuse within 12 months prior to enrollment
- Not a permanent resident in the area
- Current enrollee in Project Dulce
- Blood donation of one pint or more within the past 30 days, or plasma donation within 7 days prior to screening
- Anemia
- Type 1 or gestational diabetes
- Pregnant
- Are currently participating in another diabetes-related study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
San Ysidro Health
National City, California, 91950, United States
Scripps Whittier Diabetes Institute
San Diego, California, 92037, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emily Rose N. San Diego, PhD
Scripps Whittier Diabetes Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Corporate Vice President
Study Record Dates
First Submitted
May 10, 2022
First Posted
May 18, 2022
Study Start
October 17, 2022
Primary Completion
December 12, 2025
Study Completion
December 12, 2025
Last Updated
March 4, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share